Neuroanatomical abnormalities in behaviorally characterized APP(V717F) transgenic mice

Neurobiology of Disease

Volumn 7, Issue 2, 2000, Pages 71-85

  Dodart, Jean Cosme ^a   Mathis, Chantal ^a   Saura, Josep ^b   Bales, Kelly R ^b   Paul, Steven M ^b   Ungerer, Arielle ^a  

^a CNRS   (France)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; APP; Computer assisted image analysis; Hippocampus; Immunohistochemistry; Synaptic density; Synaptophysin; Transgenic mice

Indexed keywords

AMYLOID; SYNAPTOPHYSIN;

AMNESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN ATROPHY; CONTROLLED STUDY; MALE; MOUSE; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NONHUMAN; PRIORITY JOURNAL; RECOGNITION; SPATIAL MEMORY; TRANSGENIC MOUSE; WORKING MEMORY;

EID: 0034107615     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.1999.0278     Document Type: Article

References (43)

1. Blennow K., Bogdanovic N., Alafuzoff I., Ekman R., Davidsson P. Synaptic pathology in Alzheimer's disease: Relation to severity of dementia, but not to senile plaques, neurofibrillary tangles, or the ApoE4 allele. J. Neural Transm. 103:1996;603-618.
2. DeKosky S. T., Scheff S. W., Styren S. D. Structural correlates of cognition in dementia: Quantification and assessment of synapse change. Neurodegeneration. 5:1996;417-421.
3. Dodart J. C., Meziane H., Mathis C., Bales K. R., Paul S. M., Ungerer A. Memory and learning impairment precede amyloid deposition in the V717F PDAPP transgenic mouse. Soc. Neurosci. Abstr. 23:1997a;1637.
4. Dodart J. C., Mathis C., Ungerer A. Scopolamine-induced deficits in a two-trial object recognition task in mice. NeuroReport. 8:1997b;1173-1178.
5. Dodart J. C., Meziane H., Mathis C., Bales K. R., Paul S. M., Ungerer A. Behavioral disturbances in transgenic mice overexpressing the V717F β-amyloid precursor protein. Behav. Neurosci. 113:1999;1-9.
6. Douglas R. J. The hippocampus and behavior. Psychol. Bull. 67:1967;416-442.
7. Elghetany M. T., Saleem A. Methods for staining amyloid in tissues: A review. Stain Technol. 63:1988;201-212.
8. Ennaceur A., Neave N., Aggleton J. P. Neurotoxic lesions of the perirhinal cortex do not mimic the behavioural effects of fornix transection in the rat. Behav. Brain Res. 80:1996;9-25.
9. Ennaceur A., Aggleton J. P. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav. Brain Res. 88:1997;181-193.
10. Fraser S. P., Suh Y.-H., Djamgoz M. B. A. Ionic effects of the Alzheimer's disease β-amyloid precursor protein and its metabolic fragments. Trends Neurosci. 20:1997;67-72.
11. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagopian S., Johnson-Wood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoya-Zavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
12. Gomez-Isla T., Hollister R., West H., Mui S., Growdon J. H., Petersen R. C., Parisi J. E., Hyman B. T. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41:1997;17-24.
13. Hsiao K. K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
14. Huang X., Chen S., Tietz E. I. Immunocytochemical detection of regional protein changes in rat brain sections using computer-assisted image analysis. J. Histochem. Cytochem. 44:1996;981-987.
15. Irizarry M. C., Soriano F., McNamara M., Page K. J., Schenk D., Games D., Hyman B. T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 17:1997;7053-7059.
16. Izaki Y., Hori K., Nomura M. Dopamine and acetylcholine elevation on lever-press acquisition in rat prefrontal cortex. Neurosci. Lett. 258:1998;33-36.
17. Jarrard L. E. What does the hippocampus really do. Behav. Brain Res. 71:1995;1-10.
18. 42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Natl. Acad. Sci. USA. 94:1997;1550-1555.
19. Koo E. H., Park L., Selkoe D. J. Amyloid β-protein as a substrate interacts with extracellular matrix to promote neurite outgrowth. Proc. Natl. Acad. Sci. USA. 90:1993;4748-4752.
20. Lassmann H. Patterns of synaptic and nerve cell pathology in Alzheimer's disease. Behav. Brain Res. 78:1996;9-14.
21. Loffler J., Huber G. β-Amyloid precursor protein in various rat brain regions and during development. J. Neurochem. 59:1992;1316-1324.
22. Masliah E., Terry R. D., Alford M., DeTeresa R. Quantitative immunohistochemistry of synaptophysin in human neocortex: An alternative to method estimate density of presynaptic terminals in paraffin sections. J. Histochem. Cytochem. 38:1990;837-844.
23. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
24. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Rydel R. E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
25. Morimoto T., Ohsawa I., Takamura C., Ishiguro M., Kohsaka S. Involvement of amyloid precursor protein in functional synapse formation in cultured hippocampal neurons. J. Neurosci. Res. 51:1998a;185-195.
26. Morimoto T., Ohsawa I., Takamura C., Ishiguro M., Nakamura Y., Kohsaka S. Novel domain-specific actions of amyloid precursor protein on developing synapses. J. Neurosci. 18:1998b;9386-9393.
27. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Forss-Petter S., Pietropaolo M., Mallory M., Abraham C. R. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
28. Mumby D. G., Wood E. R., Pinel J. P. J. Object-recognition memory is only mildly impaired in rats with lesions of the hippocampus and amygdala. Psychobiology. 20:1992;18-27.
29. Neve R. L., Robakis N. K. Alzheimer's disease: A re-examination of the amyloid hypothesis. Trends Neurosci. 21:1998;15-19.
30. O'Hara B. F., Fisher S., Oster-Granite M. L., Gearhart J. D., Reeves R. H. Developmental expression of the amyloid precursor protein, growth-associated protein 43, and somatostatin in normal and trisomy 16 mice. Dev. Brain Res. 49:1989;300-304.
31. Ohsawa I., Hirose Y., Ishiguro M., Imai Y., Ishiura S., Kohsaka S. Expression, purification, and neurotrophic activity of amyloid precursor protein-secreted forms produced by yeast. Biochem. Biophys. Res. Commun. 213:1995;52-58.
32. Ohta M., Kitamoto T., Iwaki T., Ohgami T., Fukui M., Tateishi J. Immunohistochemical distribution of amyloid precursor protein during normal rat development. Dev. Brain Res. 75:1993;151-161.
33. Ohyagi Y., Takahashi K., Kamegai M., Tabira T. Developmental and differential expression of β amyloid protein precursor mRNAs in mouse brain. Biochem. Biophys. Res. Commun. 167:1990;54-60.
34. Perez R. G., Zheng H., Van der Ploeg L. H. T., Koo E. H. The β-amyloid precursor protein of Alzheimer's disease enhances neuron viability and modulates neuronal polarity. J. Neurosci. 17:1997;9407-9414.
35. Poucet B., Benhamou S. The neuropsychology of spatial cognition in the rat. Crit. Rev. Neurobiol. 11:1997;101-120.
36. Qiu W. Q., Ferreira A., Miller C., Koo E. H., Selkoe D. J. Cell surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform dependent manner. J. Neurosci. 15:1995;2157-2167.
37. Rockenstein E. M., McConlogue L., Tan H., Power M., Masliah E., Mucke L. Levels and alternative splicing of amyloid β protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease. J. Biol. Chem. 270:1995;28257-28267.
38. Schenk D., Masliah E., Lee M., Johnson-Wood K., Seubert P., Games D. The PDAPP transgenic mouse as an animal model for Aβ-induced amyloidosis and neuropathology. Alzheimer Dis. Rev. 2:1997;20-27.
39. Selkoe D. J. Cell biology of the amyloid β-protein precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10:1994;373-403.
40. Small D. H., Clarris H. L., Williamson T. G., Reed G., Key B., Mok S. S., Beyreuther K., Masters C. L., Nurcombe V. Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease. Alzheimer Dis. Rev. 1:1996;21-29.
41. Wallace W. C., Akar C. A., Lyons W. E. Amyloid precursor protein potentiates the neurotrophic activity of NGF. Mol. Brain Res. 52:1997;201-212.
42. Williamson T. G., Mok S. S., Henry A., Cappai R., Lander A. D., Nurcombe V., Beyreuther K., Masters C. L., Small D. H. Secreted glypican binds to the amyloid precursor protein of Alzheimer's disease (APP) and inhibits APP-induced neurite outgrowth. J. Biol. Chem. 271:1996;31215-31221.
43. Winocur G., Eskes G. Prefrontal cortex and caudate nucleus in conditional associative learning: Dissociated effects of selective brain lesions in rats. Behav. Neurosci. 112:1998;89-101.